Cultivating gut microbiota on a gut-on-a-chip
[vc_column width=”2/3″][vc_column_text] A complex human gut microbiome cultured in anaerobic intestine-on-a-chip A recently published paper on
and get better understanding and prediction in pre-clinical drug trial
Allowing comprehending and foreseeing human responses earlier, while also offering ethical alternatives to animal testing.
[vc_column width=”2/3″][vc_column_text] A complex human gut microbiome cultured in anaerobic intestine-on-a-chip A recently published paper on
[vc_column width=”2/3″][vc_column_text] Solid tumors are characterized by areas of hypoxic tissue heterogeneously distributed inside the tumor
[vc_column width=”2/3″][vc_column_text] Immune checkpoint modulation in renal cell carcinoma In this paper, Bedke and colleague highlight the way that patients
[vc_column width=”2/3″][vc_column_text] Immune Checkpoint Modulators as an emerging therapy Through this paper, Kim and colleagues highlight
[vc_column width=”2/3″][vc_column_text] Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity In this paper, Anagnostou and colleagues “discuss endpoints
[vc_column width=”2/3″][vc_column_text] The Challenge for Development of Valuable Immuno-oncology Biomarkers. In this paper, Mehnert JM and colleagues
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com